Dollar Tree, Inc. (DLTR) is now among the bigger bargains in its industry.
Within the last year the price ranged from $88.27 – 119.71 and there is a wide opportunity to get in. Its next earnings report will be released on Mar 04, 2020.

Cara Therapeutics, Inc.(CARA)

move, based on 5 analysts offering 12 month price targets for Cara Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $39.00 and a low forecast of $30.00. The average price target represents a 110.14% increase from the last price of $16.18.

Analysts like David Amsellem from Piper Sandler believe that we could see stock price minimum $39.00.

Another prominent analyst, Charles Duncan of Cantor Fitzgerald rates CARA as a Buy. The rating was made just 8 days ago.

Cara Therapeutics, Inc.(CARA) Recent News Reports

On average 1.5 articles are written each week about CARA but this week 1 article were written and they were 68% Bullish and 32% Bearish.

Cara Therapeutics, Inc. Target Levels

The market experts are predicting that CARA is a Strong Buy. Some other stocks to consider in this sector are: